As improved ALT classifiers and molecular signatures become available, future analyses integrating both telomerase-dependent and ALT-mediated telomere maintenance mechanisms will be critical to fully elucidate the landscape of telomere regulation across cancers. The gene discussed is GPT; the disease is cancer.